Trial intelligence / Profile preview

Pilot Study on Usage Patterns of a Novel Nicotine Mouth Spray in Smokers Motivated to Quit

2008-002498-11Phase 2Completed

Sponsor
McNeil Laboratories
Start
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of nicotine in nicotine dependence (2 arms), sponsored by McNeil Laboratories. Primary endpoint: mean hourly and daily number of spray doses used during weeks 1, 2, and 3. Started Jun 2008; status: completed.

02

Drugs

nicotine
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on 2008-002498-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002498-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call